Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

MATERNUS-Kliniken AG (0N2K) Share Price & Analysis

0N2K Stock Chart & Stats

€0.84-€0.05(-5.65%)
At close: 4:30 PM GMT
EUR 0.8EUR 1EUR 1.214 Aug25 Aug9 Sep28 Sep12 Oct27 Oct
Day’s Range
EUR 0.84 - EUR 0.84
52-Week Range
EUR 0.81 - EUR 2.98
Previous Close
EUR 0.89
Volume
88
Average Volume (3M)
1,251
Market Cap
EUR 18.98M
Enterprise Value
EUR 221.67M
Total Cash (Recent Filing)
EUR 5.05M
Total Debt (Recent Filing)
EUR 205.41M
Price to Earnings (P/E)
―
Beta
0.20
Next Earnings
Apr 23, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring Care Revenue

The residential care model is built around recurring fees from occupied facilities, supported by insurance benefits, resident contributions and social assistance where applicable. This revenue structure can provide a durable base for operations because care needs persist over time rather than depending solely on discretionary demand.

Positive Cash Generation

Positive operating cash flow across the reported years and improving free cash flow in 2025 show that the facilities are generating cash despite reported accounting losses. This supports ongoing operations and may provide some funding for investment, although the current cash generation remains insufficient to rapidly reduce debt.

Narrowing Losses

The improvement in losses and the modestly better EBIT result compared with earlier periods indicate some operational progress within a difficult earnings profile. If sustained, this trend could improve internal funding capacity and reduce the gap between cash generation and reported profitability over coming quarters.

Bears Say

Sharp Revenue Decline

A revenue decline of roughly one-third materially weakens the scale benefits of a facility-based care model and raises concerns about demand, occupancy, pricing or service mix. Lower revenue makes it harder to absorb fixed operating costs, sustain margins and generate enough cash to address the company’s financial obligations.

Highly Strained Balance Sheet

Negative shareholders’ equity reflects an impaired capital base and leaves the company with limited financial flexibility. Debt exceeding the asset base increases refinancing and covenant risk, while the weak balance sheet can restrict investment capacity and make the business more vulnerable if operating performance deteriorates.

Persistent Unprofitability

Persistent net losses and negative operating margins show that the core business has not yet converted its revenue base into sustainable profitability. Continued losses can erode the capital base, limit internally funded growth and reduce the company’s ability to withstand cost pressure or weaker facility performance.

0N2K FAQ

What was MATERNUS-Kliniken AG’s price range in the past 12 months?
MATERNUS-Kliniken AG lowest share price was €0.81 and its highest was €2.98 in the past 12 months.
What is MATERNUS-Kliniken AG’s market cap?
MATERNUS-Kliniken AG’s market cap is €18.98M.
When is MATERNUS-Kliniken AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MATERNUS-Kliniken AG’s earnings last quarter?
MATERNUS-Kliniken AG released its earnings results on Aug 20, 2026. The company reported -€0.091 earnings per share for the quarter.
Is MATERNUS-Kliniken AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MATERNUS-Kliniken AG pay dividends?
MATERNUS-Kliniken AG does not currently pay dividends.
What is MATERNUS-Kliniken AG’s EPS estimate?
MATERNUS-Kliniken AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MATERNUS-Kliniken AG have?
MATERNUS-Kliniken AG has 20,970,000 shares outstanding.
What happened to MATERNUS-Kliniken AG’s price movement after its last earnings report?
MATERNUS-Kliniken AG reported an EPS of -€0.091 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MATERNUS-Kliniken AG?
Currently, no hedge funds are holding shares in GB:0N2K
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology